TrkB (NTRK2) Human shRNA Lentiviral Particle (Locus ID 4915)
CAT#: TL320436V
NTRK2 - Human shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^7 TU/ml.
Need custom lentivirus service?
Get a free quote
CNY 11,400.00
Cited in 2 publications. |
Product images
CNY 2,950.00
CNY 1,999.00
CNY 2,700.00
Specifications
Product Data | |
Product Name | TrkB (NTRK2) Human shRNA Lentiviral Particle (Locus ID 4915) |
Locus ID | 4915 |
Synonyms | DEE58; EIEE58; GP145-TrkB; OBHD; trk-B; TRKB |
Vector | pGFP-C-shLenti |
Format | Lentiviral particles |
RefSeq | NM_001007097, NM_001018064, NM_001018065, NM_001018066, NM_001291937, NM_006180, NM_001007097.1, NM_001007097.2, NM_001018065.1, NM_006180.1, NM_006180.2, NM_006180.3, NM_006180.4, NM_001018064.1, NM_001018064.2, NM_001018066.1, NM_001018066.2, NM_001291937.1, BC031835, BC031835.1, BC031309, BC075804, NM_001369532, NM_001369533, NM_001369534, NM_001369535, NM_001369538, NM_001369539, NM_001369540, NM_001369546, NM_001369549, NM_001369550, NM_001369552, NM_001369536, NM_001369537, NM_001369541, NM_001369542, NM_001369543, NM_001369544, NM_001369545, NM_001369547, NM_001369548, NM_001369551, NM_001291937.2, NM_001007097.3, NM_001018064.3, NM_006180.6, NM_001018066.3 |
Summary | This gene encodes a member of the neurotrophic tyrosine receptor kinase (NTRK) family. This kinase is a membrane-bound receptor that, upon neurotrophin binding, phosphorylates itself and members of the MAPK pathway. Signalling through this kinase leads to cell differentiation. Mutations in this gene have been associated with obesity and mood disorders. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (2)
The use of this RNAi has been cited in the following citations: |
---|
Ovarian BDNF promotes survival, migration, and attachment of tumor precursors originated from p53 mutant fallopian tube epithelial cells
,Kang, M;Chong, KY;Hartwich, TMP;Bi, F;Witham, AK;Patrick, D;Morrisson, MJ;Cady, SL;Cerchia, AP;Kelk, D;Liu, Y;Nucci, J;Madarikan, O;Ueno, D;Shuch, BM;Yang-Hartwich, Y;,
Oncogenesis
,PubMed ID 32471985
[NTRK2]
|
TrkB induces EMT and has a key role in invasion of head and neck squamous cell carcinoma
,null,
Oncogene
,PubMed ID 20101235
[NTRK2]
|
Documents
Product Manuals |
FAQs |
SDS |